Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy.
Kang EJ, Hwang S, Lee YG, Choi JK, Shin SH, Choi YH, Lee KW, Lee HW, Kim MK, Lim ST, Yun HJ, Park SG, Kim S, Kim SB, Kim HR.
Kang EJ, et al. Among authors: yun hj.
Cancer Res Treat. 2024 Dec 23. doi: 10.4143/crt.2024.836. Online ahead of print.
Cancer Res Treat. 2024.
PMID: 39727015
Free article.